RU2010108361A - MEDICINE SET - Google Patents
MEDICINE SET Download PDFInfo
- Publication number
- RU2010108361A RU2010108361A RU2010108361/14A RU2010108361A RU2010108361A RU 2010108361 A RU2010108361 A RU 2010108361A RU 2010108361/14 A RU2010108361/14 A RU 2010108361/14A RU 2010108361 A RU2010108361 A RU 2010108361A RU 2010108361 A RU2010108361 A RU 2010108361A
- Authority
- RU
- Russia
- Prior art keywords
- organs
- overdose
- suffering
- patient
- well
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H39/00—Devices for locating or stimulating specific reflex points of the body for physical therapy, e.g. acupuncture
- A61H39/08—Devices for applying needles to such points, i.e. for acupuncture ; Acupuncture needles or accessories therefor
- A61H39/086—Acupuncture needles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H39/00—Devices for locating or stimulating specific reflex points of the body for physical therapy, e.g. acupuncture
- A61H39/002—Using electric currents
Abstract
Набор лечебных средств, предназначенный для психотерапевтического воздействия на пациента, а также уменьшения вреда, причиняемого его здоровью при употреблении как минимум одного входящего в набор лекарства, витамина, минерала или пищевой добавки, и сопутствующих такому вреду страданий больного, включающий лекарственный препарат, при приеме которого могут иметь место передозировка и/или отрицательные побочные эффекты, и/или нежелательные лекарственные реакции, связанные с негативным воздействием на органы дыхательной, и/или пищеварительной в т.ч. печень и поджелудочную железу, и/или сердечно-сосудистой, и/или мочеполовой, и/или нервной систем, и/или органы чувств, приводящим к нарушению их функции, а также одно или несколько устройств для воздействия на акупунктурные точки и/или окружающие их области, соответствующие органам и системам, эвентуально страдающим от упомянутых передозировки, эффектов и/или реакций. A set of medicinal products intended for psychotherapeutic impact on a patient, as well as to reduce the harm caused to his health when using at least one medicine, vitamin, mineral or food supplement included in the kit, and the suffering of the patient that is associated with such harm, including a medicinal product, during which an overdose and / or negative side effects and / or undesirable drug reactions associated with a negative effect on the respiratory and / or digestive organs can occur total including liver and pancreas, and / or cardiovascular, and / or genitourinary, and / or nervous systems, and / or sensory organs, leading to impaired function, as well as one or more devices for affecting acupuncture points and / or surrounding their areas corresponding to organs and systems, suffering from the above-mentioned overdose, effects and / or reactions.
Claims (1)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2010108361/14A RU2010108361A (en) | 2010-03-09 | 2010-03-09 | MEDICINE SET |
PCT/RU2011/000121 WO2011152754A2 (en) | 2010-03-09 | 2011-03-01 | Treatment set |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2010108361/14A RU2010108361A (en) | 2010-03-09 | 2010-03-09 | MEDICINE SET |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2010108361A true RU2010108361A (en) | 2011-09-20 |
Family
ID=44758243
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2010108361/14A RU2010108361A (en) | 2010-03-09 | 2010-03-09 | MEDICINE SET |
Country Status (2)
Country | Link |
---|---|
RU (1) | RU2010108361A (en) |
WO (1) | WO2011152754A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018034590A1 (en) * | 2016-08-16 | 2018-02-22 | Павел Павлович ХОРОШУТИН | Classical conditioning tool kit for attitude change used in the provision of psychological support |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9600070D0 (en) * | 1996-01-08 | 1996-01-08 | Astra Ab | New oral pharmaceutical dosage forms |
ES2687970T3 (en) * | 2002-09-05 | 2018-10-30 | Vanderbilt Royalty Sub L.P. | Compositions and kits for the removal of irritating compounds from body surfaces |
RU2376973C2 (en) * | 2005-06-23 | 2009-12-27 | Андрей Юрьевич ГАВРИЛОВ | Kit for diagnostics, treatment and prevention of diseases |
RU2314113C2 (en) * | 2006-01-26 | 2008-01-10 | Общество с ограниченной ответственностью "Биолит" | Method for reducing adverse side effects in treating for tuberculosis |
-
2010
- 2010-03-09 RU RU2010108361/14A patent/RU2010108361A/en unknown
-
2011
- 2011-03-01 WO PCT/RU2011/000121 patent/WO2011152754A2/en active Application Filing
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018034590A1 (en) * | 2016-08-16 | 2018-02-22 | Павел Павлович ХОРОШУТИН | Classical conditioning tool kit for attitude change used in the provision of psychological support |
US11097080B2 (en) | 2016-08-16 | 2021-08-24 | Pavel Pavlovich Horoshutin | Classical conditioning tool kit for attitude change used in the provision of psychological support |
Also Published As
Publication number | Publication date |
---|---|
WO2011152754A3 (en) | 2012-01-26 |
WO2011152754A2 (en) | 2011-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12020551186A1 (en) | Sustained-release dosage forms of ruxolitinib | |
IN2012DN06720A (en) | ||
NZ716627A (en) | Methods of treating behavioral symptoms of neurological and mental disorders | |
BR112015005117A2 (en) | methods of treating alzheimer's disease and its pharmaceutical compositions | |
PH12014502058A1 (en) | Pharmaceutical composition comprising empagliflozin and antiobesity drug | |
WO2018084531A3 (en) | Composition for prevention or treatment of bone disease, obesity, and lipid-related metabolic disorder | |
IL219857A0 (en) | Mitotic kinesin inhibitors, pharmaceutical compositions comprising them, uses thereof in the manufacture of a medicament for the treatment of disease or disorder in a human or animal that can be treated by inhibiting mitosis | |
EA202091999A2 (en) | APPLICATION OF DPP IV INHIBITORS | |
UA106756C2 (en) | genetic markers associated with response to interferon alpha | |
EA201101706A1 (en) | Drug medication based on diyndolylmethanum (DIM) with enhanced bioavailability and its use in the treatment of hyperplastic and inflammatory diseases | |
EP3712264A8 (en) | Cystathionine beta-synthase enzyme for treatment of homocystinuria | |
EP3318251A3 (en) | Composition for preventing or treating obesity or lipid-related metabolic disease | |
BR112013026447A2 (en) | methods for regulating sirtuin gene expression | |
EA201400973A1 (en) | PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF MENTAL, BEHAVIORAL, COGNITIVE DISORDERS | |
WO2012135528A3 (en) | Galectin-3c combination therapy for human cancer | |
PH12015502655A1 (en) | Method | |
TNSN08385A1 (en) | Delayed-release glucocorticoid treatment of rheumatoid disease | |
PH12018501790A1 (en) | Treatment of patients with homozygous familial hypercholesterolemia on lipid lowering therapy | |
RU2010108361A (en) | MEDICINE SET | |
MX350145B (en) | Proteolytic extract from bromelain for the treatment of connective tissue disorders. | |
PT1796702E (en) | Use of lavender oil for the prophylaxis and treatment of somatization disorders and posttraumatic stress disorder | |
BRPI0715740A8 (en) | SERUM TRIGLYCERIDE LOWERING AGENT | |
EA201501173A1 (en) | APPLICATION OF ADSORBED HUMANATED HOMOGENATUS AND VITAMINS OF GROUP D AND / OR THEIR ACTIVE METABOLITES FOR THE PREVENTION AND TREATMENT OF ACUTE RESPIRATORY DISEASES AND FLU | |
WO2011136585A3 (en) | Composition for treating bone disease comprising a glyceollin as an active ingredient | |
EA201270551A1 (en) | TREATMENT OF NEUROTOXICITY ASSOCIATED WITH 5-FU COMBINATIONS OR HIS DRUGS WITH DPD INHIBITORS |